# Species-specific chromatin structure and its environmental interaction in craniofacial skeletal development andvariation using cichlid fishes

> **NIH NIH R15** · CLEMSON UNIVERSITY · 2020 · $444,464

## Abstract

PROJECT SUMMARY
Variation in the craniofacial skeleton produces both a spectrum of unique faces and as well as clinical
malformations. Congenital craniofacial anomalies are one of the most common birth defects. In addition to
genetic changes, we are increasingly recognizing the importance of the physical packaging of DNA in the
regulation of gene expression and development, and the resulting genotype-phenotype relationship. A major
determinant of this epigenetic regulation is post-translational modifications of histone proteins, which alters the
structure of chromatin and access to DNA. The goal of this work is to determine how variation in chromatin
structure, in particular histone acetylation, impacts phenotypic variation of the facial skeleton. We will capitalize
on the unparalleled natural craniofacial variation among the evolutionary radiation of non-model cichlid fishes.
Given that cichlid facial variation mimics human facial variation and the molecular control of facial development
is conserved across vertebrates, this may yield novel insights into the epigenetic basis of variation in human
faces. In Aim 1, we will comprehensively quantify variation in chromatin structure and DNA accessibility using
ATAC-seq (Assay for Transposase Accessible Chromatin) and the downstream transcriptional effects using
RNA-seq. These genomic analyses will be conducted in three cichlid species with diverse adult morphologies
at three developmental time points key for facial divergence. In Aim 2, we will use pharmacological agents to
alter the activity of proteins associated with histone acetylation during distinct windows of facial development.
We will focus on four drugs that are potential sources of birth defects in humans; these drugs are in clinical
trials for treatment of diseases from cancer to heart disease, but the FDA does not currently note a potential
risk for pregnant women. Completion of this aim will determine windows of sensitivity for epigenetic changes
and potential teratogenic effects of these drugs. Applying these drugs in closely-related cichlids (comparable to
comparing different mouse strains), allows investigation of gene by environment (GxE) interactions previously
demonstrated for similar drugs. This work will address a major gap in our knowledge of the genotype-
phenotype relationship, the role of epigenetic regulation in phenotypic variation. Application of drugs to cichlid
fishes enables discovery of genetic interactions that may define sensitivity to exposure and risk of craniofacial
malformations in humans. In line with the goals of the R15 AREA grant, undergraduates will conduct
bioinformatic analyses in Aim 1, and lead pharmacological manipulations in Aim 2. Grant funds will support
four new undergraduate researchers, including summer fellowships that enable a full immersion in research
without the constraints of a full class schedule.

## Key facts

- **NIH application ID:** 10046780
- **Project number:** 1R15DE029945-01
- **Recipient organization:** CLEMSON UNIVERSITY
- **Principal Investigator:** Kara E Powder
- **Activity code:** R15 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $444,464
- **Award type:** 1
- **Project period:** 2020-07-01 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10046780

## Citation

> US National Institutes of Health, RePORTER application 10046780, Species-specific chromatin structure and its environmental interaction in craniofacial skeletal development andvariation using cichlid fishes (1R15DE029945-01). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10046780. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
